Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

April 29, 2019

Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer
April 12, 2019

Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases

- Developing Oral Therapies with Best-in-Class Potential -
April 10, 2019

Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019
April 4, 2019

Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG
April 2, 2019

Immunic Therapeutics To Present At The Needham Healthcare Conference On April 10

Show per page